High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

Podrobná bibliografie
Hlavní autoři:	Blackman, D, Porto, I, Channon, K, Banning, A
Médium:	Conference item
Vydáno:	2003

Podobné jednotky

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
Autor: Blackman, D, a další
Vydáno: (2004)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
Autor: Porto, I, a další
Vydáno: (2005)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
Autor: Nisha Ohri, MD, a další
Vydáno: (2016-01-01)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Autor: Violeta Dinesch, a další
Vydáno: (2017-04-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
Autor: Negar Faramarzi, a další
Vydáno: (2015-10-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
Autor: Sohila Refahi, a další
Vydáno: (2019-03-01)

Risk assessment score for drug eluting stent restenosis
Autor: Z. A. Gabbasov, a další
Vydáno: (2018-09-01)

Paclitaxel eluting stents versus bare metal stents restenosis
Autor: Ronald Aroche Aportela, a další
Vydáno: (2021-12-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
Autor: Mohamed Aboel-Kassem F. Abdelmegid, a další
Vydáno: (2017-04-01)

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
Autor: De Caterina, A, a další
Vydáno: (2013)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
Autor: Kakhaber Etsadashvili, a další
Vydáno: (2011-06-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
Autor: Yen-Wen Liu, a další
Vydáno: (2021-09-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
Autor: Omar A. Meelu, MS, a další
Vydáno: (2017-03-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Autor: Ganesh Paramasivam, a další
Vydáno: (2019-11-01)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
Autor: Luo Y, a další
Vydáno: (2022-02-01)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
Autor: Abizaid, A, a další
Vydáno: (2012)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
Autor: Jorge A Arroyave C, a další
Vydáno: (2012-06-01)

Safety of MRI early after implantation of a drug-eluting stent.
Autor: Porto, I, a další
Vydáno: (2004)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
Autor: Birong Liu, a další
Vydáno: (2024-12-01)

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
Autor: Kazunori Horie, MD, a další
Vydáno: (2025-01-01)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
Autor: Chengbin Zheng, a další
Vydáno: (2019-01-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
Autor: Mohammad Saifur Rohman, a další
Vydáno: (2023-07-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
Autor: Ganesh Paramasivam, a další
Vydáno: (2019-12-01)

The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
Autor: Hasan Shemirani, a další
Vydáno: (2011-09-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
Autor: Yi-Xing Yang, a další
Vydáno: (2020-01-01)

Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
Autor: Mohd Shah, Azarisman Shah, a další
Vydáno: (2011)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
Autor: Aslı Tanındı, a další
Vydáno: (2015-07-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
Autor: Murat Gençbay
Vydáno: (2015-07-01)

Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
Autor: Yu-Ling Hsu, a další
Vydáno: (2023-07-01)

In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report
Autor: I Gusti Ayu Ratna Dewi, a další
Vydáno: (2023-06-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
Autor: Xiaohang Yuan, a další
Vydáno: (2023-08-01)

Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
Autor: Dauer Cheryl, a další
Vydáno: (2005-12-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
Autor: Guillaume Marquis-Gravel, a další
Vydáno: (2017-09-01)

Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
Autor: Ponnuthurai, F, a další
Vydáno: (2007)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Autor: Ahmed Abdelaziz, a další
Vydáno: (2024-11-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
Autor: Wen-Juan Xiu, a další
Vydáno: (2018-01-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
Autor: Chih-Yuan Fang, a další
Vydáno: (2018-04-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
Autor: Alain Guidon, a další
Vydáno: (2008-01-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
Autor: Wenjie Yang, a další
Vydáno: (2025-01-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
Autor: Hongfei Xi, a další
Vydáno: (2023-03-01)